Medistim ASA Statistics

Total Valuation

Medistim ASA has a market cap or net worth of NOK 4.02 billion. The enterprise value is 3.85 billion.

Market Cap	4.02B
Enterprise Value	3.85B

Important Dates

The last earnings date was Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	May 7, 2026

Share Statistics

Medistim ASA has 18.28 million shares outstanding. The number of shares has decreased by -0.23% in one year.

Current Share Class	18.28M
Shares Outstanding	18.28M
Shares Change (YoY)	-0.23%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	2.94%
Owned by Institutions (%)	84.19%
Float	12.67M

Valuation Ratios

The trailing PE ratio is 25.25 and the forward PE ratio is 25.96.

PE Ratio	25.25
Forward PE	25.96
PS Ratio	5.75
PB Ratio	8.59
P/TBV Ratio	10.78
P/FCF Ratio	n/a
P/OCF Ratio	21.00
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	24.17
EV / Sales	5.50
EV / EBITDA	18.13
EV / EBIT	19.61
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.08.

Current Ratio	3.34
Quick Ratio	2.21
Debt / Equity	0.08
Debt / EBITDA	0.18
Debt / FCF	n/a
Interest Coverage	11.65

Financial Efficiency

Return on equity (ROE) is 35.18% and return on invested capital (ROIC) is 52.43%.

Return on Equity (ROE)	35.18%
Return on Assets (ROA)	19.85%
Return on Invested Capital (ROIC)	52.43%
Return on Capital Employed (ROCE)	37.92%
Weighted Average Cost of Capital (WACC)	10.32%
Revenue Per Employee	4.54M
Profits Per Employee	1.03M
Employee Count	154
Asset Turnover	1.13
Inventory Turnover	0.80

Taxes

In the past 12 months, Medistim ASA has paid 47.64 million in taxes.

Income Tax	47.64M
Effective Tax Rate	23.03%

Stock Price Statistics

The stock price has increased by +35.80% in the last 52 weeks. The beta is 1.06, so Medistim ASA's price volatility has been similar to the market average.

Beta (5Y)	1.06
52-Week Price Change	+35.80%
50-Day Moving Average	231.68
200-Day Moving Average	233.48
Relative Strength Index (RSI)	51.06
Average Volume (20 Days)	52,141

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medistim ASA had revenue of NOK 699.77 million and earned 159.21 million in profits. Earnings per share was 8.71.

Revenue	699.77M
Gross Profit	571.59M
Operating Income	196.20M
Pretax Income	206.85M
Net Income	159.21M
EBITDA	212.21M
EBIT	196.20M
Earnings Per Share (EPS)	8.71

Full Income Statement

Balance Sheet

The company has 212.09 million in cash and 37.50 million in debt, giving a net cash position of 174.59 million or 9.55 per share.

Cash & Cash Equivalents	212.09M
Total Debt	37.50M
Net Cash	174.59M
Net Cash Per Share	9.55
Equity (Book Value)	468.41M
Book Value Per Share	25.63
Working Capital	334.51M

Full Balance Sheet

Cash Flow

Operating Cash Flow	191.57M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 81.68%, with operating and profit margins of 28.04% and 22.75%.

Gross Margin	81.68%
Operating Margin	28.04%
Pretax Margin	29.56%
Profit Margin	22.75%
EBITDA Margin	30.33%
EBIT Margin	28.04%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 6.00, which amounts to a dividend yield of 2.73%.

Dividend Per Share	6.00
Dividend Yield	2.73%
Dividend Growth (YoY)	33.33%
Years of Dividend Growth	1
Payout Ratio	68.76%
Buyback Yield	0.23%
Shareholder Yield	3.00%
Earnings Yield	3.96%
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6